Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06387173

Enrollment

Registered

2024-04-26

Start date

2024-01-04

Completion date

2099-01-03

Last updated

2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Stage Breast Carcinoma

Brief summary

This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.

Detailed description

PRIMARY OBJECTIVE: I. To obtain observational real-life data of patients who choose this non-conventional treatment and to follow their outcomes. OUTLINE: This is an observational study. Patients have their medical records reviewed on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients undergoing cryoablation for breast cancer

Design outcomes

Primary

Measure	Time frame	Description
Prospectively track patients who undergo cryoablation for breast cancer and record post-treatment related events.	five years from last participant enrollment	record follow up of symptoms, reported complications, breast imaging findings, and results of any future biopsies related to cancer, and treatment of breast cancer.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORNimmi S Kapoor, MD

UCLA / Jonsson Comprehensive Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026